CoChat

Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro

Open access

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

AIMS: We explored the use of highly purified murine and human pluripotent stem cell (PSC)-derived cardiomyocytes (CMs) to generate functional bioartificial cardiac tissue (BCT) and investigated the role of fibroblasts, ascorbic acid (AA), and mechanical stimuli on tissue formation, maturation, and functionality. METHODS AND RESULTS: Murine and human embryonic/induced PSC-derived CMs were genetically enriched to generate three-dimensional CM aggregates, termed cardiac bodies (CBs). Addressing the critical limitation of major CM loss after single-cell dissociation, non-dissociated CBs were used for BCT generation, which resulted in a structurally and functionally homogenous syncytium. Continuous in situ characterization of BCTs, for 21 days, revealed that three critical factors cooperatively improve BCT formation and function: both (i) addition of fibroblasts and (ii) ascorbic acid supplementation support extracellular matrix remodelling and CB fusion, and (iii) increasing static stretch supports sarcomere alignment and CM coupling. All factors together considerably enhanced the contractility of murine and human BCTs, leading to a so far unparalleled active tension of 4.4 mN/mm(2) in human BCTs using optimized conditions. Finally, advanced protocols were implemented for the generation of human PSC-derived cardiac tissue using a defined animal-free matrix composition. CONCLUSION: BCT with contractile forces comparable with native myocardium can be generated from enriched, PSC-derived CMs, based on a novel concept of tissue formation from non-dissociated cardiac cell aggregates. In combination with the successful generation of tissue using a defined animal-free matrix, this represents a major step towards clinical applicability of stem cell-based heart tissue for myocardial repair.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehs349

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Fibroblasts are essential for bioartificial cardiac tissue formation from murine induced pluripotent stem cell-derived dissociated cardiomyocytes and whole cardiac bodies. ( A ) Bioartificial cardiac tissue containing single cell dissociated cardiomyocytes, only, did not consolidate and tetramethylrhodamine methyl ester fluorescence as indicator of cardiomyocyte viability decreased. ( B ) Addition of fibroblasts led to rapid remodelling of the matrix and improved cardiomyocyte survival. ( C ) a -Myosin heavy-chain Zeo R selected cardiac bodies without fibroblasts resulted in bioartificial cardiac tissue with incomplete extracellular matrix remodelling (see arrows in magnified image 1), incomplete cardiac body fusion (see magnified image 2) and lack of stability. ( D ) a -Myosin heavy-chain Zeo R selected cardiac bodies with 10% fibroblasts led to efficient cardiac body fusion (see magnified image 3), with long-term survival of actively contracting bioartificial cardiac tissue without re-emergence of Oct3/4-eGFP + cells. Scale bar: 1 mm. See also Supplementary material online, Figures S1 and S2 and Movie S1 .
Figure 1 Fibroblasts are essential for bioartificial cardiac tissue formation from murine induced pluripotent stem cell-derived dissociated cardiomyocytes and whole cardiac bodies. ( A ) Bioartificial cardiac tissue containing single cell dissociated cardiomyocytes, only, did not consolidate and tetramethylrhodamine methyl ester fluorescence as indicator of cardiomyocyte viability decreased. ( B ) Addition of fibroblasts led to rapid remodelling of the matrix and improved cardiomyocyte survival. ( C ) a -Myosin heavy-chain Zeo R selected cardiac bodies without fibroblasts resulted in bioartificial cardiac tissue with incomplete extracellular matrix remodelling (see arrows in magnified image 1), incomplete cardiac body fusion (see magnified image 2) and lack of stability. ( D ) a -Myosin heavy-chain Zeo R selected cardiac bodies with 10% fibroblasts led to efficient cardiac body fusion (see magnified image 3), with long-term survival of actively contracting bioartificial cardiac tissue without re-emergence of Oct3/4-eGFP + cells. Scale bar: 1 mm. See also Supplementary material online, Figures S1 and S2 and Movie S1 .CC-BY-NC-ND · From the PDF
Figure 2 Ascorbic acid critically affects murine induced pluripotent stem cell-derived bioartificial cardiac tissue morphology and extracellular matrix organization. ( A ) Immuno-fluorescence staining against cTnT (red)/connexin 43 (green) in sections of cardiac body/fibroblast-based induced pluripotent stem cell-derived bioartificial cardiac tissue cultivated under control conditions (left) or with ascorbic acid (right); ascorbic acid-treated bioartificial cardiac tissue showed areas with longitudinally arranged (anisotropic) cardiomyocytes with distinct cross-striation (see upper part). ( B ) Transmission electron microscopy showed more prominent cell-cell contacts between cardiomyocytes (intercalated discs, asterisks) in ascorbic acid-treated bioartificial cardiac tissue and improved orientation of sarcomeres (arrowheads). ( C ) Immuno-fluorescence staining against collagen type I (red)/titin (green) showed more prominent collagen fibre bundles in the ascorbic acid-treated group. ( D ) Transmission electron microscopy showed accumulation of collagen in the intracellular space next to cardiomyocytes and more collagen fibrils (arrowheads) in ascorbic acid-treated bioartificial cardiac tissue. (A) and (C): nuclei stained with DAPI (blue); scale bars: 20 m m. (B) and (D): scale bars: 1 m m.
Figure 2 Ascorbic acid critically affects murine induced pluripotent stem cell-derived bioartificial cardiac tissue morphology and extracellular matrix organization. ( A ) Immuno-fluorescence staining against cTnT (red)/connexin 43 (green) in sections of cardiac body/fibroblast-based induced pluripotent stem cell-derived bioartificial cardiac tissue cultivated under control conditions (left) or with ascorbic acid (right); ascorbic acid-treated bioartificial cardiac tissue showed areas with longitudinally arranged (anisotropic) cardiomyocytes with distinct cross-striation (see upper part). ( B ) Transmission electron microscopy showed more prominent cell-cell contacts between cardiomyocytes (intercalated discs, asterisks) in ascorbic acid-treated bioartificial cardiac tissue and improved orientation of sarcomeres (arrowheads). ( C ) Immuno-fluorescence staining against collagen type I (red)/titin (green) showed more prominent collagen fibre bundles in the ascorbic acid-treated group. ( D ) Transmission electron microscopy showed accumulation of collagen in the intracellular space next to cardiomyocytes and more collagen fibrils (arrowheads) in ascorbic acid-treated bioartificial cardiac tissue. (A) and (C): nuclei stained with DAPI (blue); scale bars: 20 m m. (B) and (D): scale bars: 1 m m.CC-BY-NC-ND · From the PDF
Figure 3 Comprehensive overview on functional and structural parameters of murine induced pluripotent stem cell-derived bioartificial cardiac tissue. ( A ) Maximum forces of murine induced pluripotent stem cell-derived bioartificial cardiac tissue from different treatment groups: C, control; A, ascorbic acid; G, G-stretch; AG, ascorbic acid and G-stretch; maximum contraction forces ( F max) measured after electrical pacing (25 V, 5 ms) showed high impact of AA and moderate influence of G-stretch on d14 and d21. ( B ) Passive forces increased over time (d14 to d21) and were significantly higher after ascorbic acid-treatment and G-stretch. ( C ) Analysis of bioartificial cardiac tissue sections immuno-stained against collagen type I showed strong influence of ascorbic acid on fibre width and alignment (in D , given as [1/angle dispersion %]), and of G-stretch on alignment only. ( E ) Numbers of DAPI-stained nuclei per mm 2 were significantly increased for ascorbic acid-treated bioartificial cardiac tissue. ( F ) Fluorescence intensities of TMRM in viable bioartificial cardiac tissue were moderately increased with ascorbic acid and significantly with G-stretch. ( G ) Both ascorbic acid and G-stretch significantly increased fluorescence intensities of titin staining of fixed cryosections. ( H ) Sarcomere length, determined in cross-striated cardiomyocytes after cardiac troponin T staining, was significantly increased in G-stretched bioartificial cardiac tissue. All columns are means + SEM, n ¼ 8-9 for (A) and (B), n ¼ 83-112 for (C), n ¼ 75-90 for (D), n ¼ 15-20 areas (0.3 mm 2 ) for (E), (F) and (G), n ¼ 77-184 for (H). * P ≤ 0.05; one-way analysis of variance for (C)-(H). See also Supplementary material online, Figure S3 and Movie S2 .
Figure 3 Comprehensive overview on functional and structural parameters of murine induced pluripotent stem cell-derived bioartificial cardiac tissue. ( A ) Maximum forces of murine induced pluripotent stem cell-derived bioartificial cardiac tissue from different treatment groups: C, control; A, ascorbic acid; G, G-stretch; AG, ascorbic acid and G-stretch; maximum contraction forces ( F max) measured after electrical pacing (25 V, 5 ms) showed high impact of AA and moderate influence of G-stretch on d14 and d21. ( B ) Passive forces increased over time (d14 to d21) and were significantly higher after ascorbic acid-treatment and G-stretch. ( C ) Analysis of bioartificial cardiac tissue sections immuno-stained against collagen type I showed strong influence of ascorbic acid on fibre width and alignment (in D , given as [1/angle dispersion %]), and of G-stretch on alignment only. ( E ) Numbers of DAPI-stained nuclei per mm 2 were significantly increased for ascorbic acid-treated bioartificial cardiac tissue. ( F ) Fluorescence intensities of TMRM in viable bioartificial cardiac tissue were moderately increased with ascorbic acid and significantly with G-stretch. ( G ) Both ascorbic acid and G-stretch significantly increased fluorescence intensities of titin staining of fixed cryosections. ( H ) Sarcomere length, determined in cross-striated cardiomyocytes after cardiac troponin T staining, was significantly increased in G-stretched bioartificial cardiac tissue. All columns are means + SEM, n ¼ 8-9 for (A) and (B), n ¼ 83-112 for (C), n ¼ 75-90 for (D), n ¼ 15-20 areas (0.3 mm 2 ) for (E), (F) and (G), n ¼ 77-184 for (H). * P ≤ 0.05; one-way analysis of variance for (C)-(H). See also Supplementary material online, Figure S3 and Movie S2 .CC-BY-NC-ND · From the PDF
Figure 4 Growing stretch improves structure and sub-cellular organization of murine induced pluripotent stem cell-derived bioartificial cardiac tissue. ( A ) Immuno-fluorescence staining against cTnT (red)/connexin 43 (green) of cardiac body/fibroblast-based murine induced pluripotent stem cell-derived bioartificial cardiac tissue cultivated under control conditions (left) or with G-stretch (right; notably both groups without AA). G-stretched bioartificial cardiac tissue showed large areas with uniform distribution of viable cardiomyocytes and better alignment along the longitudinal axis of the bioartificial cardiac tissue. Scale bars: 20 m m. ( B ) Transmission electron microscopy showed improved sarcomeric organization within CMs on d21 (symbols indicate sarcomere orientation) in cross-sections of G-stretched bioartificial cardiac tissue. Scale bars: 1 m m. ( C ) Immuno-fluorescence staining against cTnT (green) shows broader sarcomeric structures of G-stretched bioartificial cardiac tissue. Scale bars: 20 m m. (A) and (C) Nuclei stained with DAPI (blue). See also Supplementary material online, Figures S4 and S5 .
Figure 4 Growing stretch improves structure and sub-cellular organization of murine induced pluripotent stem cell-derived bioartificial cardiac tissue. ( A ) Immuno-fluorescence staining against cTnT (red)/connexin 43 (green) of cardiac body/fibroblast-based murine induced pluripotent stem cell-derived bioartificial cardiac tissue cultivated under control conditions (left) or with G-stretch (right; notably both groups without AA). G-stretched bioartificial cardiac tissue showed large areas with uniform distribution of viable cardiomyocytes and better alignment along the longitudinal axis of the bioartificial cardiac tissue. Scale bars: 20 m m. ( B ) Transmission electron microscopy showed improved sarcomeric organization within CMs on d21 (symbols indicate sarcomere orientation) in cross-sections of G-stretched bioartificial cardiac tissue. Scale bars: 1 m m. ( C ) Immuno-fluorescence staining against cTnT (green) shows broader sarcomeric structures of G-stretched bioartificial cardiac tissue. Scale bars: 20 m m. (A) and (C) Nuclei stained with DAPI (blue). See also Supplementary material online, Figures S4 and S5 .CC-BY-NC-ND · From the PDF
Figure 5 Gene expression and electrophysiology of optimized murine induced pluripotent stem cell-derived bioartificial cardiac tissue. ( A ) Quantitative real-time polymerase chain reaction analysis of optimized murine induced pluripotent stem cell-derived bioartificial cardiac tissue on d21 after combined ascorbic acid and G-stretch treatment demonstrated a -myosin heavy-chain, Cx40, Cx45, and collagen type I expression levels comparable with neonatal mouse heart (nH). Levels of Cx43 and b -myosin heavy chain were significantly lower than in neonatal mouse heart and argue for a rather embryonic phenotype; also, collagen type III levels were lower than in the heart; adult mouse heart (aH) shown for comparison; mean + SD from n ¼ 4-6 with polymerase chain reaction performed in triplicate; # P ≤ 0.05 to nH; § P ≤ 0.05 to aH; one-way analysis of variance. ( B ) A TMRM-labelled murine induced pluripotent stem cell-derived bioartificial cardiac tissue (d21) was plated on a microelectrode array; scale bar: 1 mm. ( C ) Spatio-temporal colour-mapping showed the excitation propagation delay in the tissue during spontaneous contraction. ( D ) Cardiomyocyte-representative field potential recordings were obtained, and administration of 10 m M isoprenaline ( E ), 1 mM lidocaine ( F ), and 30 m M quinidine ( G ) demonstrated physiological drug responsiveness in murine induced pluripotent stem cell-derived bioartificial cardiac tissue.
Figure 5 Gene expression and electrophysiology of optimized murine induced pluripotent stem cell-derived bioartificial cardiac tissue. ( A ) Quantitative real-time polymerase chain reaction analysis of optimized murine induced pluripotent stem cell-derived bioartificial cardiac tissue on d21 after combined ascorbic acid and G-stretch treatment demonstrated a -myosin heavy-chain, Cx40, Cx45, and collagen type I expression levels comparable with neonatal mouse heart (nH). Levels of Cx43 and b -myosin heavy chain were significantly lower than in neonatal mouse heart and argue for a rather embryonic phenotype; also, collagen type III levels were lower than in the heart; adult mouse heart (aH) shown for comparison; mean + SD from n ¼ 4-6 with polymerase chain reaction performed in triplicate; # P ≤ 0.05 to nH; § P ≤ 0.05 to aH; one-way analysis of variance. ( B ) A TMRM-labelled murine induced pluripotent stem cell-derived bioartificial cardiac tissue (d21) was plated on a microelectrode array; scale bar: 1 mm. ( C ) Spatio-temporal colour-mapping showed the excitation propagation delay in the tissue during spontaneous contraction. ( D ) Cardiomyocyte-representative field potential recordings were obtained, and administration of 10 m M isoprenaline ( E ), 1 mM lidocaine ( F ), and 30 m M quinidine ( G ) demonstrated physiological drug responsiveness in murine induced pluripotent stem cell-derived bioartificial cardiac tissue.CC-BY-NC-ND · From the PDF
Figure 6 Human pluripotent stem cell-derived bioartificial cardiac tissue shows high density of cardiomyocytes and well-structured tissue morphology. ( A ) Both in sections of human embryonic stem cell-derived and human induced pluripotent stem cell-derived bioartificial cardiac tissue cultivated with ascorbic acid and G-stretch, longitudinally arranged (anisotropic) cardiomyocytes with distinct cross-striation were detected by immuno-fluorescence staining against a -sarcomeric actinin (green)/vimentin (red) on d21 and d28, respectively. ( B ) Both displayed similar cell and matrix organization with longitudinal alignment of collagen type I bundles (red) and cardiomyocytes visualized by staining titin (green). ( C ) Bioartificial cardiac tissue displayed a high density of viable cardiomyocytes staining positive for Nkx2.5 (red)/titin (green); ( D ) with expression of Cx43 (green) localized between cardiomyocytes (positive for cTnT, red). Nuclei stained with DAPI (blue); scale bars: (A) 50 m m, (B), (C), and (D) 100 m m; for insets ¼ 10 m m. See also Supplementary material online, Figures S7 and S8 .
Figure 6 Human pluripotent stem cell-derived bioartificial cardiac tissue shows high density of cardiomyocytes and well-structured tissue morphology. ( A ) Both in sections of human embryonic stem cell-derived and human induced pluripotent stem cell-derived bioartificial cardiac tissue cultivated with ascorbic acid and G-stretch, longitudinally arranged (anisotropic) cardiomyocytes with distinct cross-striation were detected by immuno-fluorescence staining against a -sarcomeric actinin (green)/vimentin (red) on d21 and d28, respectively. ( B ) Both displayed similar cell and matrix organization with longitudinal alignment of collagen type I bundles (red) and cardiomyocytes visualized by staining titin (green). ( C ) Bioartificial cardiac tissue displayed a high density of viable cardiomyocytes staining positive for Nkx2.5 (red)/titin (green); ( D ) with expression of Cx43 (green) localized between cardiomyocytes (positive for cTnT, red). Nuclei stained with DAPI (blue); scale bars: (A) 50 m m, (B), (C), and (D) 100 m m; for insets ¼ 10 m m. See also Supplementary material online, Figures S7 and S8 .CC-BY-NC-ND · From the PDF
Figure 7 Optimized human pluripotent stem cell-derived bioartificial cardiac tissue show maturation towards a ventricular phenotype. Quantitative real-time polymerase chain reaction analysis of optimized human embryonic stem cell-derived bioartificial cardiac tissue on d7, d14, and d21 showed ( A ) increasing expression levels of the ventricular myosin light-chain isoform MLC2v in relation to MLC2a after combined ascorbic acid and G-stretch treatment (AG, black bars) but not in untreated controls (C, grey bars), and ( B ) increasing expression levels of Kir2.1 in both groups over time, while ( C ) expression levels of atrial natriuretic factor did not change significantly. Expression levels of human cardiac bodies on d23 of differentiation are shown for comparison, representing the starting material for bioartificial cardiac tissue preparation; mean + SD ( n ¼ 3 with polymerase chain reaction performed in triplicate; # P ≤ 0.05 to cardiac bodies; * P ≤ 0.05 between indicated groups). ( D ) Microelectrode array-based spatio-temporal colour mapping showed the excitation propagation delay in the tissue during spontaneous contraction of a human embryonic stem cell-derived bioartificial cardiac tissue on d22. ( E ) Cardiomyocyte-representative field potential recordings were obtained (black, see squares), and administration of 10 m M isoprenaline demonstrated physiological drug responsiveness (red, see circles). See also Supplementary material online, Movie S4 . Noradrenaline was added between d7 and d21 to all ascorbic acid and G-stretch-treated Matrigel TM -bioartificial cardiac tissue. Functionality of human embryonic stem cell-derived bioartificial cardiac tissue was further demonstrated by assessment of spontaneous contraction frequencies (F) and active forces (G), both at 0.6 mM Ca 2 + and in response to 0.1 m M isoprenaline (Iso) and 10 m M carbachol (CCh); values are given normalized to un-stimulated baseline levels ( ¼ 100%) as mean + SD for n ¼ 6; * P ≤ 0.05; one-way analysis of variance.
Figure 7 Optimized human pluripotent stem cell-derived bioartificial cardiac tissue show maturation towards a ventricular phenotype. Quantitative real-time polymerase chain reaction analysis of optimized human embryonic stem cell-derived bioartificial cardiac tissue on d7, d14, and d21 showed ( A ) increasing expression levels of the ventricular myosin light-chain isoform MLC2v in relation to MLC2a after combined ascorbic acid and G-stretch treatment (AG, black bars) but not in untreated controls (C, grey bars), and ( B ) increasing expression levels of Kir2.1 in both groups over time, while ( C ) expression levels of atrial natriuretic factor did not change significantly. Expression levels of human cardiac bodies on d23 of differentiation are shown for comparison, representing the starting material for bioartificial cardiac tissue preparation; mean + SD ( n ¼ 3 with polymerase chain reaction performed in triplicate; # P ≤ 0.05 to cardiac bodies; * P ≤ 0.05 between indicated groups). ( D ) Microelectrode array-based spatio-temporal colour mapping showed the excitation propagation delay in the tissue during spontaneous contraction of a human embryonic stem cell-derived bioartificial cardiac tissue on d22. ( E ) Cardiomyocyte-representative field potential recordings were obtained (black, see squares), and administration of 10 m M isoprenaline demonstrated physiological drug responsiveness (red, see circles). See also Supplementary material online, Movie S4 . Noradrenaline was added between d7 and d21 to all ascorbic acid and G-stretch-treated Matrigel TM -bioartificial cardiac tissue. Functionality of human embryonic stem cell-derived bioartificial cardiac tissue was further demonstrated by assessment of spontaneous contraction frequencies (F) and active forces (G), both at 0.6 mM Ca 2 + and in response to 0.1 m M isoprenaline (Iso) and 10 m M carbachol (CCh); values are given normalized to un-stimulated baseline levels ( ¼ 100%) as mean + SD for n ¼ 6; * P ≤ 0.05; one-way analysis of variance.CC-BY-NC-ND · From the PDF
Figure 8 Optimized human pluripotent stem cell-derived bioartificial cardiac tissue shows increased active and passive contraction forces. Functionality of human induced pluripotent stem cell-derived ( A ) and human embryonic stem cell-derived bioartificial cardiac tissue ( B ) was demonstrated by assessment of active and passive contraction forces upon electrical pacing in response to increasing preload at d28 and d21, respectively. ( C ) Maximum contraction forces of human embryonic stem cell-derived bioartificial cardiac tissue from different treatment groups: C, control, and AG, ascorbic acid and G-stretch, measured after electrical pacing (25 V, 10 ms) showed increased forces after the combined treatment on d10, d14, and d21. ( D ) With AG-treatment, human embryonic stem cell-derived bioartificial cardiac tissue passive forces increased over time from d10 to d14, and were significantly higher than in untreated controls. ( E ) Preload was increased stepwise to determine maximum active force ( F max) for human embryonic stem cell-derived bioartificial cardiac tissue treated with AG (full squares), compared with untreated controls (open squares) on d14; both curves reflect the Frank-Starling mechanism of increasing force-preload relation seen in native heart muscle. ( F ) Similarly, d14 passive force-preload relation in human embryonic stem cell-derived bioartificial cardiac tissue was significantly higher in the AG group (full squares) vs. controls (open squares). Symbols represent mean baseline force + SEM; (C) and (D) n ¼ 3-7 per group; (E) and (F) n ¼ 4-7 per group. * P ≤ 0.05 between indicated groups; # P ≤ 0.05 for all indicated data points compared with respective control at the same preload. See also Supplementary material online, Figures S7 and S9 .
Figure 8 Optimized human pluripotent stem cell-derived bioartificial cardiac tissue shows increased active and passive contraction forces. Functionality of human induced pluripotent stem cell-derived ( A ) and human embryonic stem cell-derived bioartificial cardiac tissue ( B ) was demonstrated by assessment of active and passive contraction forces upon electrical pacing in response to increasing preload at d28 and d21, respectively. ( C ) Maximum contraction forces of human embryonic stem cell-derived bioartificial cardiac tissue from different treatment groups: C, control, and AG, ascorbic acid and G-stretch, measured after electrical pacing (25 V, 10 ms) showed increased forces after the combined treatment on d10, d14, and d21. ( D ) With AG-treatment, human embryonic stem cell-derived bioartificial cardiac tissue passive forces increased over time from d10 to d14, and were significantly higher than in untreated controls. ( E ) Preload was increased stepwise to determine maximum active force ( F max) for human embryonic stem cell-derived bioartificial cardiac tissue treated with AG (full squares), compared with untreated controls (open squares) on d14; both curves reflect the Frank-Starling mechanism of increasing force-preload relation seen in native heart muscle. ( F ) Similarly, d14 passive force-preload relation in human embryonic stem cell-derived bioartificial cardiac tissue was significantly higher in the AG group (full squares) vs. controls (open squares). Symbols represent mean baseline force + SEM; (C) and (D) n ¼ 3-7 per group; (E) and (F) n ¼ 4-7 per group. * P ≤ 0.05 between indicated groups; # P ≤ 0.05 for all indicated data points compared with respective control at the same preload. See also Supplementary material online, Figures S7 and S9 .CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 201

Metadata

Authors
Kensah, G., Roa Lara, A., Dahlmann, J., Zweigerdt, R., Schwanke, K., Hegermann, J., Skvorc, D., Gawol, A., Azizian, A., Wagner, S., Maier, L. S., Krause, A., Dräger, G., Ochs, M., Haverich, A., Gruh, I., & Martin, U.
Affiliations
  • Medizinische Hochschule Hannover (DE)
  • University of Göttingen (DE)
  • Leibniz University Hannover (DE)
Corresponding author
Martin, Ulrich
Venue
European Heart Journal
Published
2012-10-26
Volume
34
Issue
15
Pages
1134-1146
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2019037987
Cited by
193
References
59
Citations by year
2026: 4 · 2025: 4 · 2024: 10 · 2023: 17 · 2022: 7 · 2021: 9 · 2020: 14 · 2019: 16 · 2018: 14 · 2017: 25 · 2016: 20 · 2015: 20 · 2014: 18 · 2013: 14 · 2012: 1
FWCI
6.80
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) (submittedVersion, cc-by-nc-nd)
  • HighWire Press Open Archive (submittedVersion)
  • GRO (submittedVersion)
  • Leibniz Universität Hannover
Funders
  • Deutsche Forschungsgemeinschaft (EXC62/1, Exc-62, DFG EXC62, DFG EXC 62/1)
  • Bundesministerium für Bildung und Forschung (01GN0958, DFG EXC 62/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
pluripotent stem cells, cardiomyocytes, fibroblasts, vitamin C, mechanical stretch, extracellular matrix remodeling, sarcomere alignment, cardiomyocyte fusion, myocardial repair, embryonic stem cells, induced pluripotent stem cells
MeSH terms
Animals, Ascorbic Acid, Bioprosthesis, Cell Line, Humans, Myocardial Contraction, Myocardium, Sarcomeres, Vitamins, Gene Expression, Cell Culture Techniques, Tissue Engineering, Myocytes, Cardiac, Cell Enlargement, Mice, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.